Compare WYETH LTD with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs ORCHID PHARMA LTD - Comparison Results

WYETH LTD     Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD ORCHID PHARMA LTD WYETH LTD/
ORCHID PHARMA LTD
 
P/E (TTM) x 27.7 -0.5 - View Chart
P/BV x 5.3 0.1 4,541.5% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 WYETH LTD   ORCHID PHARMA LTD
EQUITY SHARE DATA
    WYETH LTD
Mar-13
ORCHID PHARMA LTD
Sep-13
WYETH LTD/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs1,044194 538.4%   
Low Rs81835 2,337.1%   
Sales per share (Unadj.) Rs298.6276.5 108.0%  
Earnings per share (Unadj.) Rs57.2-79.2 -72.3%  
Cash flow per share (Unadj.) Rs58.4-43.5 -134.4%  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.80-  
Book value per share (Unadj.) Rs249.553.9 462.5%  
Shares outstanding (eoy) m22.7270.45 32.2%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.10.4 753.1%   
Avg P/E ratio x16.3-1.4 -1,125.4%  
P/CF ratio (eoy) x15.9-2.6 -605.0%  
Price / Book Value ratio x3.72.1 175.8%  
Dividend payout %29.70-   
Avg Mkt Cap Rs m21,1578,067 262.3%   
No. of employees `0000.52.8 17.6%   
Total wages/salary Rs m4002,527 15.8%   
Avg. sales/employee Rs Th13,787.46,956.1 198.2%   
Avg. wages/employee Rs Th813.0902.5 90.1%   
Avg. net profit/employee Rs Th2,643.3-1,993.0 -132.6%   
INCOME DATA
Net Sales Rs m6,78319,477 34.8%  
Other income Rs m353407 86.6%   
Total revenues Rs m7,13619,884 35.9%   
Gross profit Rs m1,6171,103 146.7%  
Depreciation Rs m272,519 1.1%   
Interest Rs m65,227 0.1%   
Profit before tax Rs m1,938-6,236 -31.1%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-5511 -1.0%   
Tax Rs m632-125 -505.0%   
Profit after tax Rs m1,301-5,580 -23.3%  
Gross profit margin %23.85.7 421.2%  
Effective tax rate %32.62.0 1,625.0%   
Net profit margin %19.2-28.7 -66.9%  
BALANCE SHEET DATA
Current assets Rs m6,98411,014 63.4%   
Current liabilities Rs m2,05632,060 6.4%   
Net working cap to sales %72.6-108.1 -67.2%  
Current ratio x3.40.3 988.8%  
Inventory Days Days9995 104.6%  
Debtors Days Days2434 71.3%  
Net fixed assets Rs m24429,440 0.8%   
Share capital Rs m227705 32.2%   
"Free" reserves Rs m5,4412,043 266.4%   
Net worth Rs m5,6683,800 149.2%   
Long term debt Rs m259,018 0.3%   
Total assets Rs m7,90146,510 17.0%  
Interest coverage x353.3-0.2 -182,957.3%   
Debt to equity ratio x02.4 0.2%  
Sales to assets ratio x0.90.4 205.0%   
Return on assets %16.5-0.8 -2,174.8%  
Return on equity %22.9-146.9 -15.6%  
Return on capital %34.0-3.7 -911.6%  
Exports to sales %0.237.9 0.6%   
Imports to sales %36.322.6 160.7%   
Exports (fob) Rs m157,378 0.2%   
Imports (cif) Rs m2,4654,406 56.0%   
Fx inflow Rs m157,513 0.2%   
Fx outflow Rs m2,6775,649 47.4%   
Net fx Rs m-2,6621,865 -142.8%   
CASH FLOW
From Operations Rs m9231,682 54.9%  
From Investments Rs m317-9,860 -3.2%  
From Financial Activity Rs m-4816,644 -7.2%  
Net Cashflow Rs m759-1,535 -49.5%  

Share Holding

Indian Promoters % 0.0 32.3 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 4.6 245.7%  
FIIs % 7.2 3.3 218.2%  
ADR/GDR % 0.0 4.6 -  
Free float % 30.4 55.3 55.0%  
Shareholders   21,978 84,811 25.9%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   STRIDES PHARMA SCIENCE  CIPLA  TORRENT PHARMA  ALEMBIC LTD  DR. REDDYS LAB  

Compare WYETH LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Economic Growth and Stock Markets: It's Not All Gloom and Doom(Podcast)

In addition to the usual stock market updates of the week, I talk about how RBI's monetary policy decision and slowing economy impacts you and your portfolio of stocks.

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Could this Smallcap Be the Next Page Industries?(Profit Hunter)

Nov 27, 2019

A single stock - Coca Cola, made Buffett billions. Here's your chance to break into the crorepati club with a single smallcap stock investment.

How We Made 12.68% in One Overnight Trade(The 5 Minute Wrapup)

Nov 25, 2019

This one trade had my subscribers laughing all the way to the bank.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Growth Stocks or Value Stocks... What Will Make You More Money in this Bull Market?(Profit Hunter)

Nov 28, 2019

Should you invest in growth stocks or value stocks to make strong returns in this market?

Two Trends to Look at as Sensex Crosses 41,000 Levels(Views On News)

Nov 26, 2019

The two trends that are playing out as Sensex touches new record high.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WYETH LTD WITH

MARKET STATS